Efg Asset Management (North America) Corp. Invitae Corp Transaction History

Efg Asset Management (North America) Corp.

  • $585 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
SELL
$2.13 - $9.01 $299,601 - $1.27 Million
-140,658 Closed
0 $0
Q1 2022

Apr 26, 2022
BUY
$6.28 - $15.59 $172,153 - $427,368
27,413 Added 24.21%
140,658 $1.12 Million
Q4 2021

Feb 18, 2022
BUY
$14.7 - $28.67 $1.66 Million - $3.25 Million
113,245 New
113,245 $1.73 Million

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email